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Background
Linaclotide is a guanylyl cyclase C (GC-C) agonist
approved for treatment of adult patients with irritable
bowel syndrome with constipation (IBS-C). Linaclotide
binding to the extracellular receptor domain of GC-C acti-
vates the intracellular catalytic domain of GC-C, resulting
in the generation of cyclic GMP (cGMP). cGMP, via a
pathway leading to activation of the cystic fibrosis trans-
membrane conductance regulator (CFTR) ion channel,
stimulates Cl- and HCO3-secretion and concomitant inhi-
bition of Na+ absorption by sodium/hydrogen exchanger
3 (NHE3), driving the efflux of water into the lumen and
accelerating bowel transit. However, the effect of linaclo-
tide on electrolyte transport in the lower gastrointestinal
tract has not yet been characterized. This study specifically
examined the effect of linaclotide on electrolyte transport
in the colon. We used an in vitro Ussing chamber assay to
measure the secretion of electrolytes in human ascending
colon segments and in rat proximal colon in response to
linaclotide treatment.
Materials and methods
Colonic mucosa was isolated using either sharp (human)
or blunt (rat) dissection and ion transport was monitored
by measuring short-circuit current (Isc).
Results
Stimulation with linaclotide elicited a concentration-
dependent short-circuit current across rat colonic epithe-
lium. The Isc response reached its maximum at 100 nM of
linaclotide with an EC50 of 9.8 nM in rat colonic mucosa.
Linaclotide at concentrations of 30 nM and 1000 nM
added to human colonic mucosa also induced a trans-
epithelial current. As the CFTR ion channel and Na-K-Cl
co-transporter NKCC1 are well-characterized transporters
regulating the flux of Cl-anions across the intestinal
epithelium, we further studied the effects of NKCC1 and
CFTR antagonists on GC-C–mediated short-circuit cur-
rent. Addition of NKCC1 inhibitor bumetanide (100 μM)
to the basolateral bath significantly inhibited linaclotide-
induced transepithelial current in human colonic mucosa.
In contrast, bumetanide had no effect on linaclotide-
induced transepithelial current in rat colonic mucosa, sug-
gesting that in the rat proximal colon, flux of Cl-anions is
mediated by alternate transporters. Preincubation of rat
colonic mucosa with the CFTR antagonist GlyH-101 atte-
nuated the sustained increase in Isc observed in response
to treatment with 100 nM linaclotide. The effect of GlyH-
101 on Isc inhibition was more profound after the colonic
epithelium was stimulated with a sub-EC50 (6 nM) con-
centration of linaclotide.
Conclusions
We have demonstrated that linaclotide treatment induces
a transepithelial ion current in the human ascending colon
and rat proximal colon. This ion current is in part driven
by Cl-anion secretion into the intestinal lumen.
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